Systemic lupus erythematosus detection reagent containing lncRNA and usage thereof
A systemic technology for lupus erythematosus, applied in the direction of DNA/RNA fragments, recombinant DNA technology, microbial measurement/testing, etc., can solve the problem of less attention to non-coding RNA, the number of diagnostic markers that cannot reach clinical applications, lupus erythematosus Problems such as protracted and repeated disease course
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Example 1 Integrated analysis based on high-throughput transcriptome data
[0031] 1. Data retrieval
[0032] The GEO (Gene Expression Omnibus) database is developed and maintained by NCBI (National Center for Biotechnology Information), and the GEO database is the largest database of gene expression data. Data retrieval is carried out by searching keywords ("lupuserythematosus,systemic"[MeSH Terms]OR systemic lupus erythematosus[AllFields]) AND "Homo sapiens"[porgn]AND"gse"[Filter], and the retrieved results are screened. The following standard datasets will be included in our research:
[0033] ①The selected data set must be the transcriptome data of the whole genome;
[0034] ② These data come from the blood of systemic lupus erythematosus case group and healthy control group;
[0035] ③ This study considers standardized or original data sets.
[0036] After screening, 6 sets of mRNA data sets and 2 sets of lncRNA data sets were obtained (see Table 1).
[0037] ...
Embodiment 2
[0045] Example 2 Fluorescent quantitative PCR verification of differentially expressed ENSG00000249309 and its adjacent gene TLR2
[0046] 1. Sample collection
[0047] For sample collection, 23 cases of peripheral blood from patients with systemic lupus erythematosus diagnosed in our hospital were selected. The cases all met the SLE diagnostic criteria revised by the American Rheumatology Association. 1mg / Kg / d) completed blood sample collection before. The normal control group consisted of 18 healthy subjects. Infection, tumor, hypertension, diabetes and other systemic diseases were excluded. There were no statistically significant differences in gender and age among the groups. Explain the purpose of the study to the research subjects, and with their consent, use EDTA anticoagulant blood collection tubes to extract 5ml of peripheral venous blood from SLE cases and healthy controls respectively, conduct plasma separation and PBMCs extraction as soon as possible, and put th...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com